ImmuPharma (LON:IMM) Trading Down 18% – Here’s What Happened

ImmuPharma plc (LON:IMM) dropped 18% during trading on Wednesday . The stock traded as low as GBX 4.60 ($0.06) and last traded at GBX 4.84 ($0.06). Approximately 61,560,121 shares changed hands during mid-day trading, an increase of 142% from the average daily volume of 25,488,205 shares. The stock had previously closed at GBX 5.90 ($0.07).

ImmuPharma Trading Down 3.7 %

The firm has a market cap of £21.65 million, a P/E ratio of -520.00 and a beta of 1.53. The business’s 50-day moving average is GBX 2.06 and its two-hundred day moving average is GBX 1.83.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.